Membrane rafts in host-pathogen interactions

被引:128
作者
Riethmueller, Joachim
Riehle, Andrea
Grassme, Heike
Gulbins, Erich
机构
[1] Univ Duisburg Essen, Dept Mol Biol, D-45122 Essen, Germany
[2] Univ Tubingen, Childrens Hosp, D-72076 Tubingen, Germany
来源
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 2006年 / 1758卷 / 12期
关键词
bacteria; viruses; infections; membrane; rafts; ceramide;
D O I
10.1016/j.bbamem.2006.07.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Central elements in the infection of mammalian cells with viral, bacterial and parasitic pathogens include the adhesion of the pathogen to surface receptors of the cell, recruitment of additional receptor proteins to the infection-site, a re-organization of the membrane and, in particular, the intracellular signalosome. Internalization of the pathogen results in the formation of a phagosome that is supposed to fuse with lysosomes to form phagolysosomes, which serve the degradation of the pathogen, an event actively prevented by some pathogens. In summary, these changes in the infected cell permit pathogens to trigger apoptosis (for instance of macrophages paralysing the initial immune response), to invade the cell and/or to survive in the cell, but they also serve the mammalian cell to defeat the infection, for instance by activation of transcription factors and the release of cytokines. Distinct membrane domains in the plasma membrane and intracellular vesicles that are mainly composed of sphingolipids and cholesterol or enriched with the sphingolipid ceramide, are critically involved in all of these events occurring during the infection. These membrane structures are therefore very attractive targets for novel drugs to interfere with bacterial, viral and parasitic infections. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:2139 / 2147
页数:9
相关论文
共 91 条
[1]
Human immunodeficiency virus Type 1 Nef associates with lipid rafts to downmodulate cell surface CD4 and class I major histocompatibility complex expression and to increase viral infectivity [J].
Alexander, M ;
Bor, YC ;
Ravichandran, KS ;
Hammarskjöld, ML ;
Rekosh, D .
JOURNAL OF VIROLOGY, 2004, 78 (04) :1685-1696
[2]
Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1 [J].
Alfsen, A ;
Iniguez, P ;
Bouguyon, E ;
Bomsel, M .
JOURNAL OF IMMUNOLOGY, 2001, 166 (10) :6257-6265
[3]
The caveolae membrane system [J].
Anderson, RGW .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :199-225
[4]
Selected lipids activate phagosome actin assembly and maturation resulting in killing of pathogenic mycobacteria [J].
Anes, E ;
Kühnel, MP ;
Bos, E ;
Moniz-Pereira, J ;
Habermann, A ;
Griffiths, G .
NATURE CELL BIOLOGY, 2003, 5 (09) :793-802
[5]
Subcellular localization of 14-3-3 proteins in Toxoplasma gondii tachyzoites and evidence for a lipid raft-associated form [J].
Assossou, O ;
Besson, F ;
Rouault, JP ;
Persat, F ;
Brisson, C ;
Duret, L ;
Ferrandiz, J ;
Mayençon, M ;
Peyron, F ;
Picot, S .
FEMS MICROBIOLOGY LETTERS, 2003, 224 (02) :161-168
[6]
Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrPSc) into contiguous membranes [J].
Baron, GS ;
Wehrly, K ;
Dorward, DW ;
Chesebro, B ;
Caughey, B .
EMBO JOURNAL, 2002, 21 (05) :1031-1040
[7]
Rituximab antiproliferative effect in B-lymphoma cells is associated with acid-sphingomyelinase activation in raft microdomains [J].
Bezombes, C ;
Grazide, S ;
Garret, C ;
Fabre, C ;
Quillet-Mary, A ;
Müller, S ;
Jaffrézou, JP ;
Laurent, G .
BLOOD, 2004, 104 (04) :1166-1173
[8]
Extensive temporally regulated reorganization of the lipid raft proteome following T-cell antigen receptor triggering [J].
Bini, L ;
Pacini, S ;
Liberatori, S ;
Valensin, S ;
Pellegrini, M ;
Raggiaschi, R ;
Pallini, V ;
Baldari, CT .
BIOCHEMICAL JOURNAL, 2003, 369 :301-309
[9]
The transmembranous domain of CD40 determines CD40 partitioning into lipid rafts [J].
Bock, J ;
Gulbins, E .
FEBS LETTERS, 2003, 534 (1-3) :169-174
[10]
CD28 SIGNALS THROUGH ACIDIC SPHINGOMYELINASE [J].
BOUCHER, LM ;
WIEGMANN, K ;
FUTTERER, A ;
PFEFFER, K ;
MACHLEIDT, T ;
SCHUTZE, S ;
MAK, TW ;
KRONKE, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (06) :2059-2068